Moreover, the administration of proteasome inhibitor MG-132 could rescue the protein level of ID1 in USP1-siRNA-treated B-ALL cells (Figure 5B), suggesting that USP1-siRNA decreased the protein expression of ID1 through proteasomal degradation. Here, ID1 is linked to acute lymphoblastic leukemia.